Company: BKYI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001437749-25-017209
Chunk: 2

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
ingencies           
         
 STOCKHOLDERS’ EQUITY         
         
 Common stock — authorized, 170,000,000 shares; issued and outstanding; 5,814,041 and 3,715,483 of $.0001 par value at March 31, 2025 and December 31, 2024, respectively   582   372 
 Additional paid-in capital   137,514,825   133,030,271 
 Accumulated other comprehensive loss   56,093   49,290 
 Accumulated deficit   (130,044,447)  (129,307,902)
 TOTAL STOCKHOLDERS’ EQUITY   7,527,053   3,772,031 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $11,183,676  $8,615,560 

See accompanying notes to the condensed consolidated financial statements.  

     3

      Table of Contents

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

       Three Months Ended 

       March 31, 

       2025 

       2024 

       Revenues 

       Services 
       
      $
      272,598

      $
      213,122

       License fees 

      1,098,758

      1,950,434

       Hardware 

      235,803

      17,647

       Total revenues 

      1,607,159

      2,181,203

       Costs and other expenses 

       Cost of services 

      98,144

      138,849

       Cost of license fees 

      72,885

      148,221

             Cost of hardware 

      108,469

      12,573

       Total costs and other expenses 

      279,498

      299,643

       Gross profit 

      1,327,661

      1,881,560

       Operating Expenses 

       Selling, general and administrative 

      1,372,524

      1,782,973

       Research, development and engineering 

      595,775

      607,521

       Total Operating Expenses 

      1,968,299